JACARDI: A eHealth and Health Literacy Educational Training to Support Older Patients With Type II Diabetes

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status: Enrolling

Conditions: Type 2 Diabetes

Treatments: Other: Educational training

Study type: Interventional

Funder types: Other

Identifiers

NCT06904690

INRCA_003_2025

Details and patient eligibility

About

The JACARDI trial is a multicenter study involving an educational training, with the general objective to improve the eHealth of older adults in relation to the management of type 2 diabetes.

Full description

The JACARDI trial is a multicentric study organized as a blended didactic and interactive educational training, with the general objective to improve the eHealth of older adults in relation to the management of type 2 diabetes, thus contributing to independent living, and reduce risks of negative consequences for the health status and quality of life.

The trial will be preceded by a pre-study, needed to personalize and finalize the contents of the training, together with the beneficiaries of the study. In particular, during the pre-study, a population with similar characteristics of the target group will be involved in focus groups to refine the contents and practicalities of the training before the recruitment starts.

The primary end-point of the JACARDI trial is the improvement of the eHealth literacy after the conduction of the training, to be measured through the eHEALS scale, after 10 weeks of training. The training consisting of 5 modules and will be conducted over 10 weeks (one session every other week), with each session lasting an average of 90 minutes.

Enrollment: 200 estimated patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Low eHealth literacy (eHeals scale ≤ 29)
• No acute or untreated medical problems
• Mini Mental State Examination (MMSE) ≥ 24
• Geriatric Depression Scale (GDS) < 2

Exclusion criteria

• A myocardial infarction or stroke within 6 months
• Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility
• Uncontrolled hypertension
• Advanced Parkinson's disease or other neuromuscular disorder
• Metastatic cancer or immunosuppressive therapy
• Significant visual or hearing impairment

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

diabetic subjects

Experimental group

Description:

Subjects with type 2 diabetes who have low eHealth literacy.

Treatment:

Other: Educational training